ArticleBiomedicines2024

MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer.

Hiroki Ozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.